Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

Argenx Raises $750m in Gross Proceeds in a Global Offering (2020-05-28)
Regulated information — Inside information argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, announced toda...
HTGF: Kumovis Closes Series A for 3D Printing in MedTech (2020-05-27)
3D printing system developer to enter new markets, accelerate growth, and enable medical device manufacturers to leverage the full potential of high-performance polymers Kumovis, the developer of the world’s first 3D printer with clean room integration, today an...
Argenx: Efgartigimod Meets Endpoint in Phase 3 in MG (2020-05-26)
> Trial met primary endpoint (p ?0.0001) > Well-tolerated; safety profile comparable to placebo > Biologics License Application on track to be submitted to U.S. Food and Drug Administration by end of 2020 > Conference call scheduled for today, May 26, 202...
Argenx Launches Proposed $500m Global Offering (2020-05-26)
Regulated information — Inside information argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, announced today ...
Enzymicals Licenses Syngulon’s Enzyme Production Technology (2020-05-16)
Enzymicals AG, a German enterprise focusing on industrial biocatalysis and Syngulon, a Belgian synthetic biology company developing original genetic technologies using bacteriocins, announce a non-exclusive license agreement which provides Enzymicals access to Syng...
Polyganics: €1.2m Grant for Liver & Pancreas Sealant Patch (2020-05-13)
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced today that it has received EUR 1.2 million in funding from the European Fund for Regional Development (EFRO) through the Northern Netherl...
IMI & Partners Announce COVID Projects with Funding of €117m (2020-05-12)
The Innovative Medicines Initiative has provisionally selected 8 projects for funding from its fast-track Call for proposals on coronavirus diagnostics and treatments. In addition, it has boosted the IMI funding pot from EUR 45 million to EUR 72 million. On top of ...
[iito] Brings Back the Past into the [LSE] Newsletter (2020-05-04)
> Starting today, the [LSE] Newsletter will include older press releases, that have recently been added to the [iito] business database > [iito] adds perspective to strategic information for top level decision makers [iito] Business Intelligence – a Germany...
Final Closing of Kurma Biofund III Fund at €160m (2020-04-29)
> Validation of Kurma Partners’ business model with the closing of its third fund dedicated to Life Sciences for a significantly larger amount than its two first funds, Kurma Biofund I (€51m) and Kurma Biofund II (€55m) > Kurma Partners goes from managing appr...
Bone Therapeutics Secures €11m in Financing (2020-04-29)
BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces that it secured EUR 11.0 million financing. The financing will be used to advance both of it...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] – Putting Information into Context 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)